We are live on ! Find out more
DIM

DLK Investment Management Portfolio holdings

AUM $235M
1-Year Est. Return 12.41%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+12.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$261M
AUM Growth
+$19M
Cap. Flow
+$4.45M
Cap. Flow %
1.7%
Top 10 Hldgs %
38.45%
Holding
118
New
7
Increased
44
Reduced
20
Closed
5

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$3.13M
2
WMT icon
Walmart Inc
WMT
+$1.27M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$122K
4
V icon
Visa
V
+$120K
5
AAPL icon
Apple
AAPL
+$91.8K

Sector Composition

Rank Sector Weight
1 Technology 20.92%
2 Healthcare 16%
3 Industrials 12.97%
4 Financials 11.55%
5 Consumer Staples 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTCS icon
101
BTCS Inc
BTCS
$55.3M
$36.6K 0.01%
31,590
HRTX icon
102
Heron Therapeutics
HRTX
$60M
$35.6K 0.01%
17,890
HKD
103
AMTD Digital
HKD
$506M
$34.6K 0.01%
10,245
AUROW
104
Aurora Innovation Warrant
AUROW
$299M
$31.7K 0.01%
38,262
ADAP
105
DELISTED
Adaptimmune Therapeutics
ADAP
$29K 0.01%
30,512
KEEL
106
Keel Infrastructure Corp
KEEL
$2.02B
$28.5K 0.01%
13,500
QSI icon
107
Quantum-Si Incorporated
QSI
$181M
$16.8K 0.01%
19,000
AREN icon
108
Arena Group
AREN
$76.6M
$13.5K 0.01%
16,800
+3,000
+22% +$2.61K
RVMDW icon
109
Revolution Medicines Inc Warrant
RVMDW
$128M
$10.8K ﹤0.01%
77,000
ME
110
DELISTED
23andMe Holding Co
ME
$6.38K ﹤0.01%
917
BNGO icon
111
Bionano Genomics
BNGO
$13.3M
$5.61K ﹤0.01%
206
LYRA
112
DELISTED
LYRA THERAPEUTICS INC
LYRA
$3.08K ﹤0.01%
240
AKTS
113
DELISTED
Akoustis Technologies Inc
AKTS
$2.55K ﹤0.01%
28,500
CLDI icon
114
Calidi Biotherapeutics
CLDI
$4.01M
-11
Closed -$4.16K
DNA icon
115
Ginkgo Bioworks
DNA
$508M
-462
Closed -$6.17K
TGT icon
116
Target
TGT
$68.8B
-21,109
Closed -$3.13M
PRST
117
DELISTED
Presto Technologies, Inc. Common Stock
PRST
-10,000
Closed -$700
SHPW
118
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
-16,825
Closed -$11.9K

Similar funds

DLK Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, DLK Investment Management held 118 positions worth $261M, up 7.9% from $242M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

DLK Investment Management's Q3 2024 filing shows 7 new, 44 increased, 20 reduced and 5 closed positions. Its largest new stake was Crane Co: 5,654 shares worth $895K. The largest sale was Target, an estimated $3.13M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • DLK Investment Management's largest Q3 2024 buy was Crane Co: 5,654 shares worth $895K.
  • DLK Investment Management added most to Amazon in Q3 2024, an estimated $2.85M increase.
  • DLK Investment Management's biggest Q3 2024 reduction was Walmart Inc, cutting an estimated $1.27M.
  • DLK Investment Management fully exited Target in Q3 2024, selling an estimated $3.13M.
  • DLK Investment Management's ten largest holdings make up 38% of its $261M portfolio in Q3 2024.
  • DLK Investment Management opened 7 new positions and closed 5 in Q3 2024.
  • DLK Investment Management's portfolio value rose 7.9% quarter-over-quarter to $261M.

Based on DLK Investment Management's 13F filing for Q3 2024, filed 9 Oct 2024.